Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components

Transfus Sci. 1998 Dec;19(4):343-6. doi: 10.1016/s0955-3886(98)00060-5.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Blood Component Transfusion / economics
  • Blood Component Transfusion / instrumentation
  • Blood Component Transfusion / methods
  • Blood Component Transfusion / standards*
  • Cell Separation / economics*
  • Cost-Benefit Analysis
  • Creutzfeldt-Jakob Syndrome / economics
  • Creutzfeldt-Jakob Syndrome / prevention & control*
  • Government Agencies
  • Guidelines as Topic
  • Hematologic Diseases / economics
  • Hematologic Diseases / therapy
  • Humans
  • Intraoperative Care / economics
  • Length of Stay
  • Leukocytes* / chemistry
  • Postoperative Care / economics
  • Postoperative Complications / economics
  • Postoperative Complications / prevention & control
  • Safety
  • Surgical Procedures, Operative
  • Transfusion Reaction
  • United Kingdom